~~<i id='D7B449E6F8'><strike id='D7B449E6F8'><tt id='D7B449E6F8'><pre id='D7B449E6F8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：explore 2025-10-02 01:08:44 - browse：7197

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： How housing is health care on Long Island

hotspot

Wikipedia

entertainment

focus

entertainment

3:16UkrainiansoldiersfireamortartowardsRussianpositionsatthefrontline,nearBakhmut,Donetskregion,Ukra

WSS

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

New definition of a human embryo proposed amid rapid advances

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

As Maui death toll rises, number of missing remains unclear

Telehealth for opioid use disorder is lifesaving

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Wikipedia

hotspot

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How housing is health care on Long Island

Bright Health sells Medicare Advantage business to Molina

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

United colonoscopy coverage change 'may cost lives,' doctors say

Generate Biomedicines machine learning biotech raises $273M

Bright Health sells Medicare Advantage business to Molina

As Maui death toll rises, number of missing remains unclear

Alkermes shareholders re

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Wikipedia

Congress must give Medicare recipients genetic counseling access

New definition of a human embryo proposed amid rapid advances

Liz Cheney makes 1st public comment since Trump's election interference indictments

Clinical trials must include more disabled people

The boys, now 6, who are gene therapy’s ‘edge case’ problem

White House touts steps to stem shortages of cancer treatments

entertainment

focus

entertainment

entertainment